Clinical Trial Update: A Study to Assess Efficacy and Safety of Bezafibrate in Patients With Primary Biliary Cholangitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating bezafibrate for primary biliary cirrhosis to assess efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cirrhosis

Drugs mentioned

• Bezafibrate (bezafibrate)

Snippet

Sponsor: Instituto Mexicano del Seguro Social | Conditions: Primary Biliary Cirrhosis | Phase 3 | Status: UNKNOWN